Product Program year 2023 Source: CMS Open Payments

Solosec

Drug Obstetrics/Gynecology

NDC 27437-051-01

Open in the dashboard

General payments

$78,629

2,380 payments

Research payments

$162,730

6 payments

Through program year 2023, $78,629 in general payments and $162,730 in research payments were reported against Solosec (Obstetrics/Gynecology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2023 Research $99,841 3
2022 General $7,650 8
2022 Research $62,890 3
2021 General $70,979 2,372

Breakdown

Who paid General payments · program years 2021–2022
  1. Lupin Inc. $78,629 2,380 payments
Top recipients General payments · program year 2022
  1. James Lewis Gastroenterology · Washington, DC $7,013 92% · 1 payment
  2. Christina Muzny Infectious Disease · Birmingham, AL $218 3% · 2 payments
  3. Chemen Neal Obstetrics & Gynecology · Indianapolis, IN $130 2% · 1 payment
  4. Susan Spadt Nurse Practitioner · Bryn Mawr, PA $106 1% · 1 payment
  5. Olivia Van Gerwen Infectious Disease · Birmingham, AL $88 1% · 1 payment

The top 5 of 7 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Gastroenterology Internal Medicine $7,013 92% · 1 practitioner
  2. Infectious Disease Internal Medicine $305 4% · 2 practitioners
  3. Obstetrics & Gynecology $130 2% · 1 practitioner
  4. Nurse Practitioner $106 1% · 1 practitioner
  5. Nurse Practitioner, Primary Care Nurse Practitioner $84 1% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. District of Columbia $7,013 92% · 1 recipient
  2. Alabama $305 4% · 2 recipients
  3. Indiana $130 2% · 1 recipient
  4. Pennsylvania $106 1% · 1 recipient
  5. Nebraska $84 1% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

2,380 general · 6 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record